Bridgefront Capital, LLC Axsome Therapeutics, Inc. Transaction History
Bridgefront Capital, LLC
- $278 Million
- Q4 2024
A detailed history of Bridgefront Capital, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 10,555 shares of AXSM stock, worth $1.38 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
10,555Holding current value
$1.38 Million% of portfolio
0.32%Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
350Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$531 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$512 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$433 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$193 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$182 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.62B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...